CANNABINOIDS ENHANCE HUMAN B-CELL GROWTH AT LOW NANOMOLAR CONCENTRATIONS

被引：149
作者：
DEROCQ, JM
SEGUI, M
MARCHAND, J
LEFUR, G
CASELLAS, P
机构：
[1] Department of Immunology, Sanofi Recherche
来源：
FEBS LETTERS | 1995年 / 369卷 / 2-3期
关键词：
CANNABINOID; IMMUNOMODULATION; B-CELL ACTIVATION; CP55,940; TRIANGLE-9-TETRAHYDROCANNABINOL; WIN55212-2;
D O I：
10.1016/0014-5793(95)00746-V
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
This study examined the effect of cannabinoid ligands on human tonsillar B-cells activated either through cross-linking of surface immunoglobulins or ligation of the CD40 antigen. The two synthetic cannabinoids, CP55,940 and WIN55212-2, as well as Delta(9)-tetrahydrocannabinol (THC), the psychoactive component of marijuana, caused a dose-dependent increase of B-cell proliferation and displayed EC(50) at low nanomolar concentrations. This cannabinoid-induced enhancing activity mas inhibited by pertussis toxin which suggested a G-protein-coupled receptor process. In addition, the absence of antagonistic effect of SR141716A, a specific CB1 receptor antagonist, together with the demonstration that human B-cells displayed large amount of CB2 receptor mRNAs, led us to assume that the growth enhancing activity observed on B-cells at very low concentrations of cannabinoids could be mediated through the CB2 receptor.
引用
收藏
页码：177 / 182
页数：6
相关论文
共 25 条
[1]   TETRAHYDROCANNABINOL TREATMENT SUPPRESSES GROWTH RESTRICTION OF LEGIONELLA-PNEUMOPHILA IN MURINE MACROPHAGE CULTURES [J].
ARATA, S ;
KLEIN, TW ;
NEWTON, C ;
FRIEDMAN, H .
LIFE SCIENCES, 1991, 49 (06) :473-479
[2]   LONG-TERM HUMAN B-CELL LINES DEPENDENT ON INTERLEUKIN-4 AND ANTIBODY TO CD40 [J].
BANCHEREAU, J ;
DEPAOLI, P ;
VALLE, A ;
GARCIA, E ;
ROUSSET, F .
SCIENCE, 1991, 251 (4989) :70-72
[3]   CANNABINOID-RECEPTOR EXPRESSION IN HUMAN-LEUKOCYTES [J].
BOUABOULA, M ;
RINALDI, M ;
CARAYON, P ;
CARILLON, C ;
DELPECH, B ;
SHIRE, D ;
LEFUR, G ;
CASELLAS, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 214 (01) :173-180
[4]   INTERLEUKIN-13 IS A B-CELL STIMULATING FACTOR [J].
DEFRANCE, T ;
CARAYON, P ;
BILLIAN, G ;
GUILLEMOT, JC ;
MINTY, A ;
CAPUT, D ;
FERRARA, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) :135-143
[5]   ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR [J].
DEVANE, WA ;
HANUS, L ;
BREUER, A ;
PERTWEE, RG ;
STEVENSON, LA ;
GRIFFIN, G ;
GIBSON, D ;
MANDELBAUM, A ;
ETINGER, A ;
MECHOULAM, R .
SCIENCE, 1992, 258 (5090) :1946-1949
[6]   ANANDAMIDE, AN ENDOGENOUS CANNABIMIMETIC EICOSANOID, BINDS TO THE CLONED HUMAN CANNABINOID RECEPTOR AND STIMULATES RECEPTOR-MEDIATED SIGNAL-TRANSDUCTION [J].
FELDER, CC ;
BRILEY, EM ;
AXELROD, J ;
SIMPSON, JT ;
MACKIE, K ;
DEVANE, WA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7656-7660
[7]  
FISHERSTENGER K, 1993, J PHARMACOL EXP THER, V267, P1558
[8]  
GALIEGUE S, 1995, IN PRESS EUR J BIOCH
[9]   MARIJUANA AND IMMUNITY [J].
HOLLISTER, LE .
JOURNAL OF PSYCHOACTIVE DRUGS, 1992, 24 (02) :159-164
[10]  
KAMINSKI NE, 1992, MOL PHARMACOL, V42, P736
123